Larynx Flashcards

1
Q

The peak incidence of larynx cancer

A

50-60 years old, more common in men than women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Location of larynx cancer

A

65% occur in the true glottis
30% in the supraglottis
5% in the subglottis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Risk factors of larynx cancer

A

Usually associated with smoking (10 fold risk) and alcohol consumption
It maybe due to occupational exposure
Or use of voice extensively

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Most common pathology of larynx cancer

A

SCC is the most dominant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Signs and symptoms of larynx cancer

A

True glottic tumours affect speech (hoarseness)

Advanced tumours may cause difficulty breathing and pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

The spread of larynx cancer

A

Lymph node spread only if an extensive disease that is creeping superiorly into the supraglottic region

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

T1 stage larynx cancer (glottis)

A

Tumour limited to vocal cords with normal mobility
T1a: tumour limited to one vocal cord
T1a: tumour involves both vocal cords

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

T2 stage larynx cancer (glottis)

A

Tumour extends to supraglottis or subglottis with impaired vocal cord mobility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

T3 stage larynx cancer (glottis)

A

Tumour limited to the larynx with vocal cord fixation OR invasion of paraglottic space OR inner cortex of thyroid cartilage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

T4 stage larynx (glottis)

A

T4a: moderately advanced local disease
T4b: very advanced local disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

T1 stage larynx (supraglottis)

A

T1: the tumour is limited to one subsite of the supraglottis with normal vocal cord mobility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

T2 stage larynx (supraglottis)

A

Tumour invades mucosa or more than one adjacent structure without fixation of the larynx.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

T3 stage laynx (supraglottis)

A

Limited to larynx with vocal cord fixation or invades post cricoid cartilage, pre-epiglottic space or para-glottic space

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

T4 stage larynx (supraglottis)

A

T4a: moderately advanced local disease
T4b: very advanced local disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

T1 stage larynx (subglottis)

A

Limited to subglottis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

T2 stage larynx (subglottis)

A

Extends to vocal cords with normal or impaired mobility

17
Q

T3 stage larynx (subglottis)

A

limited to larynx with vocal cord fixation

18
Q

T4 stage larynx (subglottis)

A

T4a: moderately advanced local disease
T4b: very advanced local disease

19
Q

N1 stage head and neck (except nasopharynx, oropharynx, hypopharynx, and thyroid)

A

Single ipsilateral lymph node, <3cm in greatest dimension

20
Q

N2 stage head and neck (except nasopharynx, oropharynx, hypopharynx, and thyroid)

A

N2a: Single ipsilateral lymph node >3 but <6cm in greatest dimension
N2b: in multiple ipsilateral lymph nodes none >6cm in greatest dimension
N2c: metastasis in bilateral or contralateral lymph nodes >6cm in the greatest dimension.

21
Q

N3 stage head and neck (except nasopharynx, oropharynx, hypopharynx, and thyroid)

A

Metastasis in a lymph node >6cm in greatest dimension

22
Q

Lymphatic draining of the larynx

A

Glottis: extremely rare nodal involvement
Subglottis: into the peritracheal and low cervical nodes
Supraglottis: into the peritracheal, cervical, submental, and submaxillary

23
Q

Expected direct spread of larynx tumour

A
True cords
False cords
Arytenoid muscles
Epiglottis
Hypopharynx
Aryepiglottic folds
Venticles
24
Q

Treatment method for in-situ larynx cancer

A

Endoscopic stripping
Laser excision
RT
Or stringent follow-up

25
Q

Treatment method for T1-2 stage larynx cancer

A

RT is preferred, voice quality is better with RT, easily accomplished with minimal side effects
Surgery is reserved for salvage

26
Q

Treatment method for T3-4 stage larynx cancer

A

Fixed cord lesions indicate deep muscle &/or cartilage infiltrations.
Some can be treated with RT with surgery to salvage
If bilateral then surgery is required

27
Q

Negative prognosis factors for head and neck cancers

A
Tumours that cross the midline
Invasion of the lamina propria or submucosa
Poorly differentiated
Non-SCC
Fixed lymph nodes
Cranial nerve involvement
Vascular invasion
28
Q

Larynx anatomy

A

Is contiguous with the lower portion of the pharynx above.

It extends from the tip of the epiglottis at the level of the C3 vertebrae to the lower border of the cricoid cartilage.

29
Q

Common TDF’s for treatment of larynx cancer

A

The hypofractionated dose of 6600cGy/220cGy/# to the gross tumour with 5400cGy to elective lymph nodes.
A conventional fractionation dose of 7000cGy at 200cGy/# to the gross tumour volume and a lower dose to elective lymph nodes.

30
Q

Radiation therapy of larynx cancer

A

Typically treated with two opposing lateral fields.
The typical field size of 5x5cm for T1/T2 lesions up to 6x6cm.
Daily fraction doses of 200cGy or more results in superior outcomes to smaller daily doses.
The treatment of small fields for early glottic cancers rarely in severe complications.
Large T3/T4 lesions are treated with RT alone, salvage surgery can be done at the time of recurrence.
RT is the best method for voice preservation.
Equivalent control rates have been seen for both surgery and RT, usually decided at the discretion of the RO.

Supraglottic tumours tend to be large and bulky with spread superiorly to the epiglottis, and lymph node spread in 40-50% of cases therefore the treatment area is much larger than glottic tumours.

  • surgery can control 80% of supraglottic tumours while RT offers 75% local control.
  • RT for T3/T4 supraglottic nodes in contraindicated.

Subglottic lesions are treated with total laryngectomy with postoperative radiation therapy.

31
Q

Survival rates of larynx cancer

A
Glottic cancer: 
- 80-90% without cord fixation 
- 50-60% with cord fixation
Supraglottic cancer:
- 60-75% 5-year survival without involved lymph nodes
- 30-50% with involved nodes